Evidence map›Paper›PMID 35296466›Full record

ReviewBMJ global health2022

Fifteen days in December: capture and analysis of Omicron-related travel restrictions.

Jordan Schermerhorn, Alaina Case, Ellie Graeden, Justin Kerr, Mackenzie Moore, Siobhan Robinson-Marshall, Trae Wallace, Emily Woodrow, Rebecca Katz

Open access · goldAbstract readReview
In one paragraph

Review in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!Acta bio-medica : Atenei Parmensis · 2022
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jordan SchermerhornCenter for Global Health Science and Security, Georgetown University, Washington, District of Columbia, USA.ORCID 0000-0002-5765-1838
Alaina CaseTalus Analytics, Boulder, Colorado, USA.
Ellie GraedenCenter for Global Health Science and Security, Georgetown University, Washington, District of Columbia, USA.ORCID 0000-0002-1265-9756
Justin KerrTalus Analytics, Washington, District of Columbia, USA.
Mackenzie MooreCenter for Global Health Science and Security, Georgetown University, Washington, District of Columbia, USA.
Siobhan Robinson-MarshallCenter for Global Health Science and Security, Georgetown University, Washington, District of Columbia, USA.
Trae WallaceTalus Analytics, Boulder, Colorado, USA.
Emily WoodrowCenter for Global Health Science and Security, Georgetown University, Washington, District of Columbia, USA.
Rebecca KatzCenter for Global Health Science and Security, Georgetown University, Washington, District of Columbia, USA Rebecca.Katz@georgetown.edu.
Georgetown University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the identification of the Omicron variant of the SARS-CoV-2 virus in late November 2021, governments worldwide took actions intended to minimise the impact of the new variant within their borders. Despite guidance from the WHO advising a risk-based approach, many rapidly implemented stringent policies focused on travel restrictions. In this paper, we capture 221 national-level travel policies issued during the 3 weeks following publicisation of the Omicron variant. We characterise policies based on whether they target travellers from specific countries or focus more broadly on enhanced screening, and explore differences in approaches at the regional level. We find that initial reactions almost universally focused on entry bans and flight suspensions from Southern Africa, and that policies continued to target travel from these countries even after community transmission of the Omicron variant was detected elsewhere in the world. While layered testing and quarantine requirements were implemented by some countries later in this 3-week period, these enhanced screening policies were rarely the first response. The timing and conditionality of quarantine and testing requirements were not coordinated between countries or regions, creating logistical complications and burdening travellers with costs. Overall, response measures were rarely tied to specific criteria or adapted to match the unique epidemiology of the new variant.

Indexed as

COVID-19HumansMass ScreeningSARS-CoV-2Travelcontrol strategiesCOVID-19health policyscreening

Identifiers

PMID35296466
PMCPMC8928247
OpenAlexW4220832092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.